The Utility of Mass Spectrometry in Defining Minimal Residual Disease in Treated Multiple Myeloma Patients

被引：0
|
作者：
Campbell, Lauren [1 ]
Lau, I-Jun [2 ]
Ramasamy, Karthik [3 ]
Sadler, Ross [1 ]
机构：
[1] Oxford Univ Hosp NHS Fdn Trust, Oxford, England
[2] Botnar Inst, Oxford, England
[3] Radcliffe Dept Med, Oxford, England
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-184
引用
收藏
页码：S144 / S145
页数：2
相关论文
共 50 条
  • [11] Using Mass Spectrometry to Assess Disease Status in Treated Multiple Myeloma Patients
    Campbell, Lauren
    Ramasamy, Karthik
    Sadler, Ross
    BLOOD, 2023, 142
  • [12] Comparison of EasyM, a clonotypic mass spectrometry assay, and EuroFlow minimal residual disease assessment in multiple myeloma
    Zhao, Jessie
    Khong, Tiffany
    Gorniak, Malgorzata
    Khaled, Abir
    Mcdonald, Zac
    Reynolds, John
    Mithraprabhu, Sridurga
    Bingham, Nicholas
    Lim, Suehli
    Wong, Daniel
    Johnston, Anna
    Motorna, Olga
    Murphy, Nicholas
    Quach, Hang
    Yang, Liqiang
    Spencer, Andrew
    HAEMATOLOGICA, 2025, 110 (03) : 764 - 767
  • [13] Minimal Residual Disease Monitoring By Targeted Mass Spectrometry Allows Early Relapse Detection in Multiple Myeloma
    Noori, Somayya
    Wijnands, Charissa
    Langerhorst, Pieter
    Nadal, Simon
    Bonifay, Vincent
    Stingl, Christoph
    Touzeau, Cyrille
    Luider, Theo
    Dejoie, Thomas
    Jacobs, Johannes
    Vanduijn, Martijn
    BLOOD, 2022, 140 : 2349 - 2350
  • [14] Evaluation of Easym, a Clonotypic Mass Spectrometry Assay, and Euroflow Minimal Residual Disease Assessment in Multiple Myeloma
    Zhao, Jessie
    Khong, Tiffany T.
    Gorniak, Malgorzata
    Khaled, Abir
    McDonald, Zac
    Reynolds, John
    Wong, Daniel
    Bingham, Nicholas
    Johnston, Anna M.
    Motorna, Olga
    Murphy, Nicholas E.
    Quach, Hang
    Yang, Liqiang
    Spencer, Andrew
    BLOOD, 2023, 142
  • [15] Minimal Residual Disease in Multiple Myeloma
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) : 2523 - 2526
  • [16] Minimal residual disease for multiple myeloma
    Avet-Loiseau, Herve
    Corre, Jill
    HEMATOLOGIE, 2019, 25 : 36 - 39
  • [17] Minimal residual disease in multiple myeloma
    Moukalled, Nour
    Malard, Florent
    Bazarbachi, Ali
    Mohty, Mohamad
    PRESSE MEDICALE, 2025, 54 (01):
  • [18] The role of minimal residual disease evaluation for patients with multiple myeloma
    Eun, Yoon Sang
    Kim, Hyun-Young
    Cho, Duck
    Kim, Seok Jin
    Kim, Kihyun
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S80 - S80
  • [19] MINIMAL RESIDUAL DISEASE IN THE CLINICAL PRACTICE OF MULTIPLE MYELOMA PATIENTS
    Cedena, M. T.
    Puig, N.
    Paiva, B.
    Perez, A.
    De Arriba, F.
    Cuellar, C.
    Blanchard, M. J.
    Martinez-Chamorro, C.
    Casanova, M.
    Sirvent, M.
    Rodriguez-Otero, P.
    Martinez-Lopez, J.
    Mateos, M., V
    San Miguel, J. F.
    Lahuerta, J. J.
    HAEMATOLOGICA, 2019, 104 : 15 - 15
  • [20] Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal Implications
    Charalampous, Charalampos
    Kourelis, Taxiarchis
    FRONTIERS IN ONCOLOGY, 2022, 11
12345